Browse > Article

Association of P53, VEGF and E-Cadherin Expression in Thyroid Papillary Carcinoma  

Cho Hyun-Jin (Department of Surgery, College of Medicine, Chosun University)
Seo Chae-Hong (Department of Pathology, College of Medicine, Chosun University)
Park Jin-Sil (College of Medicine, Chosun University, Graduate School)
Publication Information
Korean Journal of Head & Neck Oncology / v.18, no.1, 2002 , pp. 23-29 More about this Journal
Abstract
Mutation of the P53 tumor suppressor gene playa major role in the development of many carcinomas, namely in the colon, breast and bladder, whereas the role played by such mutations in thyroid carcinogenesis remains controversial. Vascular endothelial growth factor (VEGF) induces proliferation of endothelial cells, stimulates angiogenesis, and increases vascular permeability. Increased VEGF expression has been associated with poor clinical outcomes in many malignancies E-cadherin, a calcium-dependent transmembrane glycoprotein, is an adhesion molecule Expression of p53, VEGF and E-cadherin was assessed immunohistochemically in 19 tall columnar variant of papillary carcinoma, 24 common papillary carcinoma and 7 follicular carcinoma. The aim of this study was to evaluate the expression of P53,VEGF and E-cadherin as a potential maker for the prognosis of thyroid carcinomas. The results are as follows: 1) There were no significance in any clinical parameters examined among tall columnar variant of papillary carcinoma, common papillary carcinoma and follicular carcinoma. 2) The expression of P53 demonstrated low in tall columnar variant of papillary carcinoma, common papillary carcinoma and follicular carcinoma, but a significantly high in regional lymph node metastasis. 3) The expression of VEGF demonstrated a significantly high in regional lymph node metastasis than those without metastasis in papillary thyroid carcinoma. 4) The expression of E-cadherin demonstrated less often among papillary carcinomas with lymph node metastasis than in those without metastasis in papillary thyroid carcinoma. In conclusion, it is suggested that VEGF and E-cadherin will be useful for the diagnosis of thyroid carcinoma and serves as a biological marker for thyroid carcinoma lymph node metastasis.
Keywords
Thyroid papillary cancer; P53; VEGF; E-cadherin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Johnson TL, Lloyd RV,Thompson NW, Beierwaltes WH, Sisson JC : Prognostic implications of the tall cell variant ofpapillary thyroid carcinoma. Am J Surg Pathol. 1988 ; 12 : 22-27   DOI   PUBMED   ScienceOn
2 Terry JH, St. John SA, Karkowski FJ, et al : Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg. 1994 ; 168 : 459-461   DOI   ScienceOn
3 Ruter A, Dreifus J, Jones M, Nishiyama R, Lennquist S : Overexpression of p53 in tall cell variants of papillary thy-roid carcinomo. Surgery. 1996 ; 120 : 1046-1050   DOI   PUBMED   ScienceOn
4 Guidi AJ, Abu-Jawdeh G, Berse B : 'Vascular permeability factor (Vascular endothelial growth factor. expression and angiogenesis in cervical neoplasia.' J Natl Cancer Inst. 1995 ; 87 : 1237-1245
5 Fellmer PT, Sato K, Tanaka R, et al : vaseular endothelial growth faetor-c gene expression in papillary and follicular thyroid cancinomas. Surgery. 1999 ;126 (6) : 1056-1061   DOI   ScienceOn
6 Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL : The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate With the size of papillary thyroid carcinoma in children and young adults. Thyroid. 2000 ; 10 (4) : 349-357   DOI   ScienceOn
7 Scheumman GF, Hoang-Vue, Cetin Y, Gimm 0, Behrends J, Von Wasielewski R, Georgii S, Birchmeier W, Von Zurmuhlen A, Dralle H : Clinical Significance of Escadherin as a prognostic marker in throid carcinomas. J Clin Endocrinol Metal. 1995 ; 80 (7) : 2168-2172   DOI   ScienceOn
8 Hedinger C : Histologic typing of thyroid tumors. In : International histological classification of tumours. vol 11. Geneva: World Heath Organization, 1974
9 Flint A, Davenport RD, Lloyd RV : The tall cell variant ofpapillary carcinoma ofthe thyroid. Comparison with the com-mon form of papillary carcinoma by DNA and morpho-metric analysis. Arch Pathol Lab Med. 1991 ; 115 : 169-171
10 Naito A, IwaseH, Kuzushima T, Nakamura T, Kobayashis : Clinical significance of E-cadherin expressin in thyroid neoplasm. ; Surg Oncol. 2001 ; 76 (3) : 176-180
11 Kinsella AR, Green B, Lepts GC, Hill CS, Bowie G, Taylor, BA : 'The role of the cell-cell adhesion molecule E-cadherin in large bowel tomour cell invasion and metastasis.' Br J Cancer. 1993 ; 67 : 904-909   DOI   PUBMED   ScienceOn
12 Ito T, Seyama T, Mizuno T, et al : Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas ofthe thyroid gland. Cancer Res. 1992 ; 52 : 1369-1371   PUBMED
13 Pignattelli M, Ansari TW, Gunter P : 'Loss of membranous Ecadherin expression in pancreatic cancer. correlation with lymph node metastasis, high grade, and advanced stage.' J Pathol. 1994 ; 174 : 243-248
14 Raycroft L, Wu H, Lozano G : Transcriptional activa-tion by wild-type but not transforming mutants ofthe p53 anti-oncogene. Science. 1990 ; 249 : 1049-51   DOI   PUBMED
15 Shimovama Y, Hirohash S, Hirano S : 'Cadherin cell adhesion molecules in human epithelial tissue and carcinomas.' Cancer Res. 1989 ; 49 : 2128-2133
16 Shiozaki H, Tahara H, Oka H : 'Expression of immunoreactive E-cadherin adhesion molecules in human cancers.' Am J Pathol. 1991 ; 139 : 27-23
17 van den Brekel MWM, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freenal JL : Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngo-Scope. 1997 ; 107 : 254-259.   DOI   ScienceOn
18 Klein M, Vignaud 1M, Hennoguin V, et al : Increased expression of the vascular endothelial growth factor is a prejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001 ; 86 (2) : 656-658   DOI   ScienceOn
19 Soares P, Berex G, Van Roy F, Sobrinho-Simoes M : E-cadherin gene alterations are rare events in thyroid tumors. Int S cancer. 1997 ; 6 ; 70 (I) : 32-38
20 Walgenbach S, Sternheim E, Bittinger F, Gorges R, Andreas J, Junginger T : Prognostic value of E-cadherin in papillary thyroid carcinoma. Chirurg. 1998 ; 69 (2) : 186-190   DOI   ScienceOn
21 Ostrowski ML, Merino MJ : Tell cell variant ofpapillary thyroid carcinoma. Am J Surg Pathol. 1996 ; 20 : 964-974   DOI   ScienceOn
22 Dobashi Y, Sakamoto A, Sugimora H, et al : Overexpression of p53 as a possible prognostic factor in human thyroid car-cinoma. Am J Surg Pathol. 1993 ; 17 : 375-381   DOI   ScienceOn
23 De Vries C, Escobedo JA., Veno H, Houck K, Ferrara N, Williams LT : 'The fms-like tyrosine kinase, a receptor for vascular endothelial growthfactor.' Science. 1992 ; 255 : 989-991   DOI   PUBMED